514 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Applied Medical Technology recalled 840 NutraGlide Nasal Feeding Tubes on August 12, 2025. The tubes may have distal tips that detach unexpectedly, posing a risk to patients. Healthcare providers and patients must stop using the device immediately and follow recall instructions.
Applied Medical Technology recalled 390 NutraGlide Nasal Feeding Tubes on August 12, 2025, due to a risk of distal tips detaching. This recall affects models distributed in Massachusetts and Rhode Island. Patients and healthcare providers must stop using these devices immediately.
Applied Medical Technology recalled 1,780 NutraGlide Nasal Feeding Tubes on August 12, 2025, after reports of distal tips detaching. This recall affects tubes distributed in Massachusetts and Rhode Island. The detachment poses a high risk for patients requiring enteral nutrition.
Applied Medical Technology recalled 200 NutraGlide Nasal Feeding Tubes on August 12, 2025. The distal tips may detach under lower than expected forces, posing a risk to patients. This recall affects devices distributed in Massachusetts and Rhode Island.
Lannett Company recalled 8,544 bottles of Lisdexamfetamine Dimesylate Capsules on August 11, 2025. The recall occurred due to a labeling mix-up where 40 mg capsules were mislabeled as 30 mg. This issue poses a high risk to consumers who may receive incorrect dosages.
Agilent Technologies recalled 67 units of FLEX Monoclonal Mouse Anti-Human CD20cy on August 11, 2025. The recall stems from the potential for weak staining leading to false negative results in B-cell identification. Healthcare providers must cease use immediately and follow recall instructions.
Agilent Technologies Denmark ApS recalled 65 units of its FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26 on August 11, 2025. The recall stems from potential weak staining that could lead to false negative CD20 identification. Healthcare providers and patients should stop using the product immediately.
Agilent Technologies Denmark ApS recalled 4,145 units of FLEX Monoclonal Mouse Anti-Human CD20cy on August 11, 2025. The recall stems from potential weak staining that may lead to false negative CD20 identification. Healthcare providers and patients must stop using the product immediately.
Quallent Pharmaceuticals recalled 3,591 bottles of Duloxetine Delayed-Release Capsules on August 8, 2025. The recall stems from CGMP deviations regarding an impurity exceeding safety limits. Consumers should stop using the product immediately and contact their healthcare provider.
Baxter Healthcare Corporation recalled 14,400 units of its Continu-Flo solution set on August 8, 2025. The recall follows customer reports of tubing separation that pose serious risks. Healthcare providers and patients must stop using the device immediately.
Glenmark Pharmaceuticals Inc. recalled 22,656 bottles of Theophylline extended-release tablets on August 8, 2025. The recall follows reports of failed dissolution specifications that could impact medication efficacy. Consumers should stop using the product and consult healthcare providers immediately.
Philips Medical Systems Nederland B.V. recalled its IntelliSpace Cardiovascular Software 8.0.0.4 on August 8, 2025. The recall affects four units distributed nationwide, particularly in Georgia, North Carolina, and Texas. The software displays outdated information, posing a significant risk to patient safety.
Schiller Ag recalled 266 units of the Argus PB-3000 on August 8, 2025. The vital sign monitoring instrument may trigger an error message during blood pressure measurements. The recall affects devices distributed nationwide in Montana, Wisconsin, and Illinois.
Medline Industries recalled 22 sterile convenience kits on August 8, 2025, after discovering they had not been sterilized. The affected models include DYNJ0382730O and DYNJ61038B. This recall impacts states including Florida, Maryland, New Jersey, and Tennessee.
Medline Industries recalled 88 units of its Sterile Convenience Kits on August 8, 2025. The kits were labeled as sterile but did not undergo the required sterilization process. Healthcare providers and patients must stop using these kits immediately.
Glenmark Pharmaceuticals recalled 4,800 bottles of Carvedilol Tablets on August 7, 2025. The recall stems from CGMP deviations leading to high levels of nitrosamine impurities. Consumers should stop using the product immediately and consult healthcare providers for guidance.
Glenmark Pharmaceuticals recalled 44,328 bottles of Carvedilol Tablets, USP, 3.125 mg on August 7, 2025. The recall follows the discovery of N-Nitroso Carvedilol I impurity above acceptable levels. Consumers should stop using this medication immediately and consult their healthcare providers.
Glenmark Pharmaceuticals recalled 6,432 bottles of Carvedilol Tablets on August 7, 2025. The recall stems from CGMP deviations due to the presence of a nitrosamine impurity above acceptable levels. Consumers should stop using the product immediately and contact healthcare providers for guidance.
Guangzhou Ariel Biotech recalled Séfralls Hair Generation Serum on August 7, 2025. The recall affects an unknown number of units due to the product's non-compliance with child-resistant packaging standards. The defective packaging poses a serious poisoning risk to children if ingested.
SEASPINE Orthopedics recalled 74 units of the Reef TA Inserter on August 6, 2025. The device may cause difficulties in disengaging implants, leading to prolonged surgeries. Healthcare providers should stop using the device immediately and follow recall instructions.
Hi-Tech Pharmaceuticals recalled 85,950 units of Quercetin dietary supplements on August 6, 2025. The recall stems from unapproved drug claims and misbranding. Consumers should stop using the product and seek refunds immediately.
Westminster Pharmaceuticals recalled 4,456 bottles of Metoprolol Tartrate Tablets on August 6, 2025. The recall follows the detection of a nitrosamine, N-nitroso-metoprolol, above acceptable daily intake levels. Consumers should immediately stop using this medication and consult healthcare providers.
Glenmark Pharmaceuticals recalled 14,976 bottles of Carvedilol Tablets on August 6, 2025. The recall follows findings of N-Nitroso Carvedilol Impurity-1 above FDA limits. Consumers should stop using the product immediately and contact their healthcare provider.
Olympus Corporation of the Americas recalled 103,731 units of the ViziShot 2FLEX aspiration needle on August 6, 2025. The recall stems from a risk of undetected, deformed a-traumatic tips that could affect patient safety. The product is distributed worldwide, including the US, Australia, and Germany.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.